Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	phosphatidylinositol biosynthetic process	VAC14 CDIPT	2.42e-04	132	4	2	GO:0006661
GeneOntologyBiologicalProcess	phosphatidylinositol metabolic process	VAC14 CDIPT	4.01e-04	170	4	2	GO:0046488
GeneOntologyBiologicalProcess	glycerophospholipid biosynthetic process	VAC14 CDIPT	6.52e-04	217	4	2	GO:0046474
GeneOntologyBiologicalProcess	glycerolipid biosynthetic process	VAC14 CDIPT	9.92e-04	268	4	2	GO:0045017
GeneOntologyBiologicalProcess	phospholipid biosynthetic process	VAC14 CDIPT	9.92e-04	268	4	2	GO:0008654
GeneOntologyBiologicalProcess	glycerophospholipid metabolic process	VAC14 CDIPT	1.41e-03	320	4	2	GO:0006650
GeneOntologyBiologicalProcess	phospholipid metabolic process	VAC14 CDIPT	2.30e-03	410	4	2	GO:0006644
GeneOntologyBiologicalProcess	glycerolipid metabolic process	VAC14 CDIPT	2.52e-03	429	4	2	GO:0046486
GeneOntologyBiologicalProcess	organophosphate biosynthetic process	VAC14 CDIPT	5.60e-03	644	4	2	GO:0090407
GeneOntologyBiologicalProcess	lipid biosynthetic process	VAC14 CDIPT	8.83e-03	813	4	2	GO:0008610
GeneOntologyBiologicalProcess	organophosphate metabolic process	VAC14 CDIPT	1.71e-02	1142	4	2	GO:0019637
MousePheno	abnormal diencephalon morphology	VAC14 INSM1	2.64e-03	298	4	2	MP:0000830
MousePheno	abnormal somatic sensory system morphology	VAC14 OPN1SW	1.41e-02	702	4	2	MP:0000959
Pathway	REACTOME_PHOSPHOLIPID_METABOLISM	VAC14 CDIPT	1.13e-03	196	4	2	MM14591
Pathway	REACTOME_PHOSPHOLIPID_METABOLISM	VAC14 CDIPT	1.31e-03	211	4	2	M649
Pathway	REACTOME_METABOLISM_OF_LIPIDS	VAC14 CDIPT	1.09e-02	620	4	2	MM15193
Pathway	REACTOME_METABOLISM_OF_LIPIDS	VAC14 CDIPT	1.61e-02	757	4	2	M27451
Interaction	MFF interactions	OPN1SW CDIPT	4.50e-04	176	4	2	int:MFF
Interaction	MGST3 interactions	VAC14 CDIPT	1.05e-03	270	4	2	int:MGST3
Interaction	ARL13B interactions	VAC14 CDIPT	1.46e-03	318	4	2	int:ARL13B
Interaction	ERGIC3 interactions	VAC14 CDIPT	1.66e-03	340	4	2	int:ERGIC3
Interaction	LNPK interactions	VAC14 CDIPT	1.81e-03	355	4	2	int:LNPK
Interaction	ATG9A interactions	VAC14 CDIPT	2.83e-03	445	4	2	int:ATG9A
Interaction	IFITM3 interactions	VAC14 CDIPT	3.75e-03	513	4	2	int:IFITM3
Interaction	HSCB interactions	VAC14 CDIPT	9.33e-03	817	4	2	int:HSCB
Interaction	LMBR1L interactions	VAC14 CDIPT	1.24e-02	946	4	2	int:LMBR1L
Coexpression	GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_UP	CDIPT INSM1	1.59e-04	136	4	2	M1894
Coexpression	GSE28783_CTRL_ANTI_MIR_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_DN	VAC14 CDIPT	3.41e-04	199	4	2	M8356
Coexpression	GSE3039_CD4_TCELL_VS_NKT_CELL_UP	CDIPT INSM1	3.44e-04	200	4	2	M6426
Coexpression	GSE339_EX_VIVO_VS_IN_CULTURE_CD4POS_DC_UP	VAC14 CDIPT	3.44e-04	200	4	2	M5129
Coexpression	GSE17721_CTRL_VS_CPG_4H_BMDC_UP	VAC14 OPN1SW	3.44e-04	200	4	2	M3761
Coexpression	GSE39382_IL3_VS_IL3_IL33_TREATED_MAST_CELL_DN	VAC14 INSM1	3.44e-04	200	4	2	M9539
Coexpression	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP	OPN1SW CDIPT	1.09e-02	1151	4	2	M1103
Coexpression	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP	OPN1SW CDIPT	1.23e-02	1226	4	2	MM979
ToppCell	distal-3-Hematologic-Myeloid_Dendritic_Type_1\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	VAC14 INSM1	1.15e-04	198	4	2	b21227c7366ef79b36048509a91d2d35fd5e4956
ToppCell	distal-Hematologic-Myeloid_Dendritic_Type_1-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	VAC14 INSM1	1.16e-04	199	4	2	3860f30114b54abff91898308df71b8b4e05b51e
ToppCell	distal-Hematologic-Myeloid_Dendritic_Type_1\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	VAC14 INSM1	1.16e-04	199	4	2	6fc8c321e2ddd802b9c8edfe16e006c7d4d862fc
Drug	reverse T	CDIPT INSM1	3.81e-05	58	4	2	CID000064973
Drug	2'-deoxy-3'-thiacytidine	OPN1SW CDIPT	8.62e-05	87	4	2	CID000003877
Drug	PtdIns(4)P	VAC14 CDIPT	1.23e-04	104	4	2	CID000643965
Drug	2-amino-5-oxohexanoate	OPN1SW CDIPT	2.02e-04	133	4	2	CID000440805
Drug	p-chloromercuribenzoate	OPN1SW CDIPT	2.23e-04	140	4	2	CID000008747
Drug	AC1L9R2Z	VAC14 CDIPT	3.22e-04	168	4	2	CID000453624
Drug	PtdIns(3)P	VAC14 CDIPT	3.49e-04	175	4	2	CID000643964
Drug	AC1OAGFW	VAC14 CDIPT	3.86e-04	184	4	2	CID006857352
Drug	Methotrexate [59-05-2]; Up 200; 8.8uM; HL60; HG-U133A	VAC14 CDIPT	4.15e-04	191	4	2	2041_UP
Drug	AC1OAGKW	VAC14 CDIPT	4.24e-04	193	4	2	CID006857413
Drug	Norfloxacin [70458-96-7]; Down 200; 12.6uM; PC3; HT_HG-U133A	VAC14 CDIPT	4.37e-04	196	4	2	2090_DN
Drug	Sulfaguanidine [57-67-0]; Up 200; 18.6uM; PC3; HG-U133A	VAC14 CDIPT	4.37e-04	196	4	2	1913_UP
Drug	troglitazone; Up 200; 10uM; SKMEL5; HG-U133A	VAC14 CDIPT	4.42e-04	197	4	2	504_UP
Drug	Ketorolac tromethamine [74103-07-4]; Down 200; 10.6uM; PC3; HT_HG-U133A	VAC14 CDIPT	4.42e-04	197	4	2	7286_DN
Drug	nifedipine; Up 200; 10uM; MCF7; HG-U133A	VAC14 INSM1	4.42e-04	197	4	2	335_UP
Drug	troglitazone; Up 200; 10uM; HL60; HG-U133A	VAC14 CDIPT	4.46e-04	198	4	2	370_UP
Drug	Spironolactone [52-01-7]; Up 200; 9.6uM; HL60; HG-U133A	VAC14 CDIPT	4.46e-04	198	4	2	1380_UP
Disease	age at menarche	VAC14 INSM1	2.36e-03	594	4	2	EFO_0004703

Protein segments in the cluster

Peptide	Gene	Start	Entry
FYFMPCCPLTASSFY	CDIPT	26	O14735
AQVFPCKYCPATFYS	INSM1	466	Q01101
GSFCVCYVPYAAFAM	OPN1SW	256	P03999
CSPSTPTMNSYFYKF	VAC14	516	Q08AM6